Inactive Instrument

Health House International

Equities

HHI

AU0000141368

Health House International Limited Reports Consolidated Earnings Results for the Year Ended 30 June 2020

April 14, 2021 at 09:22 pm EDT

Health House International Limited reported consolidated earnings results for the year ended 30 June 2020. For the year, the company reported revenue of £3,181,030. Operating loss of £1,311,337. Loss after income tax of £1,339,924.

Latest news about Health House International

Health House International to be Removed from Australian Bourse's Official List	23-05-17	MT
Creso Pharma Limited completed the acquisition of Health House International Limited.	23-05-15	CI
Health House International Discloses Release of Shares from Escrow	23-04-12	MT
Health House International Limited Reports Earnings Results for the Half Year Ended December 31, 2022	23-03-10	CI
Health House International Limited Auditor Raises 'Going Concern' Doubt	22-12-21	CI
Health House International CEO to Step Down	22-11-24	MT
Health House International Limited Announces Resignation of Paul Mavor as COO, Effective 2 December 2022	22-11-24	CI
Health House International Limited Announces Resignation of David Attwood, CEO, Effective 19 March 2023	22-11-24	CI
COVID-19 Resurgence in China Pushes Down Australian Shares	22-11-21	MT
Creso Pharma Signs Deal to Acquire Health House; Creso Shares Fall 9%	22-11-21	MT
Health House International Limited Announces Resignation of Henrik Sprengel as Executive Director	22-11-15	CI
Sabine Jacker completed the acquisition of THCinol/CBDinol CanPharma GmbH from Health House International Limited.	22-11-15	CI
Health House International Selling German Subsidiary for $0.99	22-11-01	MT
Sabine Jacker executed a binding terms sheet to accquire THCinol/CBDinol CanPharma GmbH from Health House International Limited for Ã‡1.	22-10-31	CI
Health House International Limited announced that it has received AUD 0.4 million in funding from Celtic Capital Pty. Ltd.	22-09-04	CI
Health House International Limited Reports Earnings Results for the Full Year Ended June 30, 2022	22-08-31	CI
Health House Subsidiary Secures Supply of Cannabis Extract for German Market	22-08-17	MT
Creso Pharma Limited signed a non-binding term sheet to acquire Health House International Limited for AUD 5.3 million.	22-07-28	CI
Zelira Therapeutics Limited cancelled the acquisition of Health House International Limited.	22-06-21	CI
Health House International Posts 8.4% Growth in Fiscal Q2 Cash Receipts	22-04-26	MT
Health House International Limited Reports Earnings Results for the Half Year Ended December 31, 2021	22-02-28	CI
Zelira Therapeutics to Acquire Health House International	22-02-23	MT
Zelira Therapeutics Limited signed a basic agreement to acquire Health House International Limited for AUD 0.7 million.	22-02-23	CI
Health House International's German Subsidiary to Offer Medical Cannabis Training Courses	22-01-09	MT
Health House Subsidiary to Supply Cannabis Flowers, Extracts to German Insurance Funds; Shares Rise 3%	21-12-14	MT

Chart Health House International

Duration

Period

More charts

Company Profile

Health House International Limited is an international distributor specializing in the distribution of medicinal cannabis products across Australasia, United Kingdom and Europe. The Company is a fully licensed and regulated specialized importer, exporter, consolidator and distributor of medicinal cannabis products, distributing medicinal cannabis products to pharmacies, prescribers, specialist medicinal cannabis clinics and researchers across Australasia. It supplies pharmacies, hospital, government departments, veterinarians and other wholesalers with medicinal cannabis and general pharmaceutical products across the United Kingdom and Europe. The Company also integrates education of patients and healthcare professionals in the use of medicinal cannabis as a core part of its activities and is developing digital tools to enable a holistic understanding of usage.

Sector

More about the company